Sleep doctors Ft. Myers, Bonita Springs, Cape Coral, Lehigh, Estero | Somnas Sleep Apnea, Insomnia, Sleep Disorder

Major study finds common steroid reduces deaths among patients with severe Covid-19

In March 2020, the RECOVERY (Randomised Evaluation of COVid-19 thERapY) trial was established as a randomised clinical trial to test a range of potential treatments for COVID-19, including low-dose dexamethasone (a steroid treatment). Over 11,500 patients have been enrolled from over 175 NHS hospitals in the UK. On 8 June, recruitment to the dexamethasone arm was halted since, in the view of the trial Steering Committee, sufficient patients had been enrolled to establish whether or not the drug had a meaningful benefit. A total of 2104 patients were randomised to receive dexamethasone 6 mg once per day (either by mouth or by intravenous injection) for ten days and were compared with 4321 patients randomised to usual care alone. Among the patients who received usual care alone, 28-day mortality was highest in those who required ventilation (41%), intermediate in those patients who required oxygen only (25%), and lowest among those who did not require any respiratory intervention (13%). Dexamethasone reduced deaths by one-third in ventilated patients (rate ratio 0.65 [95% confidence interval 0.48 to 0.88]; p=0.0003) and by one fifth in other patients receiving oxygen only (0.80 [0.67 to 0.96]; p=0.0021). There was no benefit among those patients who did not require respiratory support (1.22 [0.86 to 1.75]; p=0.14).

Source: https://www.recoverytrial.net/files/recovery_dexamethasone_statement_160620_v2final.pdf

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top
Sleep well, live well

Starting on October 11, 2023, Allergy Sleep & Lung Care (ASLC) will no longer be affiliated with GenesisCare due to their bankruptcy.

ASLC will be reopening as an independent practice at our Healthpark office on or after October 30, 2023.

Please don’t hesitate to reach out to us through any of the following contact channels:

Phone/text: 239-932-3023 / 239-437-6670

Email: 


 
A partir del 11 de octubre de 2023, Allergy Sleep & Lung Care (ASLC) ya no formará parte de GenesisCare debido a su quiebra.

ASLC volverá a abrir como una práctica independiente en nuestra oficina de Healthpark a partir del 30 de octubre de 2023 o después de esa fecha.

No dudes en ponerte en contacto con nosotros a través de cualquiera de los siguientes canales:

Teléfono/mensaje de texto: 239-932-3023 / 239-437-6670

Correo electrónico: 

This website stores cookies on your computer so that we can give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

SUBSCRIBE TO NEWSLETTER

Somnas offers state-of-the-art diagnostic options to identify specific sleep disorders and manage them using the latest treatments and therapies with an individualized treatment plan to ensure long-term optimal outcomes.